Xeris Biopharma Holdings Inc logo

Xeris Biopharma Holdings Inc

NEW
STU:2B30 (USA)   Ordinary Shares
€ 6.96 -0.11 (-1.56%) Aug 5
135.25
P/B:
108.20
Market Cap:
€ 1.21B ($ 1.40B)
Enterprise V:
€ 1.34B ($ 1.55B)
Volume:
200.00
Avg Vol (2M):
2.12K
Trade In:

Xeris Biopharma Holdings Inc (STU:2B30) Dividend

Xeris Biopharma Holdings Inc (STU:2B30) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -6.8%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: STU:2B30 Dividend

Does Xeris Biopharma Holdings Inc (STU:2B30) pay a dividend?

Xeris Biopharma Holdings Inc (STU:2B30) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Xeris Biopharma Holdings Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Xeris Biopharma Holdings Inc has returned capital to shareholders via buybacks at a rate of -6.8% over the past 3 years.

What are dividend-paying alternatives to Xeris Biopharma Holdings Inc?

For dividend-paying alternatives in Xeris Biopharma Holdings Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.